SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-009812
Filing Date
2023-03-30
Accepted
2023-03-30 17:01:09
Documents
77
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1499751
2 ex3-5.htm EX-3.5 1993
3 ex4-3.htm EX-4.3 27632
4 ex23-1.htm EX-23.1 3178
5 ex31-1.htm EX-31.1 19556
6 ex31-2.htm EX-31.2 19430
7 ex32-1.htm EX-32.1 5743
8 ex32-2.htm EX-32.2 5764
9 form10-k_001.jpg GRAPHIC 11739
10 form10-k_002.jpg GRAPHIC 7982
11 form10-k_003.jpg GRAPHIC 20530
12 form10-k_004.jpg GRAPHIC 15100
13 form10-k_005.jpg GRAPHIC 21507
14 ex3-5_001.jpg GRAPHIC 198738
15 ex3-5_002.jpg GRAPHIC 423058
  Complete submission text file 0001493152-23-009812.txt   7176886

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE gtbp-20221231.xsd EX-101.SCH 55853
17 XBRL CALCULATION FILE gtbp-20221231_cal.xml EX-101.CAL 51503
18 XBRL DEFINITION FILE gtbp-20221231_def.xml EX-101.DEF 185808
19 XBRL LABEL FILE gtbp-20221231_lab.xml EX-101.LAB 430131
20 XBRL PRESENTATION FILE gtbp-20221231_pre.xml EX-101.PRE 298991
71 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 737174
Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40023 | Film No.: 23781544
SIC: 2834 Pharmaceutical Preparations